Australia's first fully integrated mRNA vaccine facility could help the nation avoid billions in costs from the next pandemic, as Moderna defends a controversial government deal as a necessary investment.
Having an onshore capability to manufacture mRNA vaccines from start to finish could save the nation $4.8 billion during pandemics across the next 30 years, an independent report by Oxford Economics reveals.
